Nintedanib selectively inhibits the activation and tumour-promoting effects of fibroblasts from lung adenocarcinoma patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/bjc2017270.pdf
Reference47 articles.
1. Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with ImageJ. Biophotonics Int 11 (7): 36 42.
2. Awasthi N, Schwarz RE (2015) Profile of nintedanib in the treatment of solid tumors: the evidence to date. Oncotargets Ther 8: 3691–3701.
3. Bertolini G, D'Amico L, Moro M, Landoni E, Perego P, Miceli R, Gatti L, Andriani F, Wong D, Caserini R, Tortoreto M, Milione M, Ferracini R, Mariani L, Pastorino U, Roato I, Sozzi G, Roz L (2015) Microenvironment-modulated metastatic CD133(+)/CXCR4(+)/EpCAM(−) lung cancer-initiating cells sustain tumor dissemination and correlate with poor prognosis. Cancer Res 75 (17): 3636–3649.
4. Bhowmick NA, Neilson EG, Moses HL (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432 (7015): 332–337.
5. Bissell MJ, Hines WC (2012) Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 17 (3): 320–329.
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic targeting of TGF‐β in lung cancer;The FEBS Journal;2024-07-31
2. Aberrant TIMP‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma;Cancer Science;2024-03-12
3. Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer;International Journal of Nanomedicine;2024-03
4. Single‑agent nintedanib suppresses metastatic osteosarcoma growth by inhibiting tumor vascular formation;Oncology Letters;2024-01-25
5. Biomimetic Nanoplatform for Dual‐Targeted Clearance of Activated and Senescent Cancer‐Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer;Small;2024-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3